NO20013456L - Functionalized heterocycles as chemokine receptor modulators - Google Patents

Functionalized heterocycles as chemokine receptor modulators

Info

Publication number
NO20013456L
NO20013456L NO20013456A NO20013456A NO20013456L NO 20013456 L NO20013456 L NO 20013456L NO 20013456 A NO20013456 A NO 20013456A NO 20013456 A NO20013456 A NO 20013456A NO 20013456 L NO20013456 L NO 20013456L
Authority
NO
Norway
Prior art keywords
chemokine receptor
receptor modulators
useful
modulators
final products
Prior art date
Application number
NO20013456A
Other languages
Norwegian (no)
Other versions
NO20013456D0 (en
Inventor
Geraldine C Harriman
Christine Nylund Kolz
Jay R Luly
Bruce David Roth
Yuntao Song
Bharat Kalidas Trivedi
Original Assignee
Millenium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millenium Pharmaceuticals Inc filed Critical Millenium Pharmaceuticals Inc
Publication of NO20013456D0 publication Critical patent/NO20013456D0/en
Publication of NO20013456L publication Critical patent/NO20013456L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Abstract

Foreliggende oppfinnelse er en ny serie av funksjonaliserte heterocykliske grupper som chemokin-reseptor-modulatorer med formel l lukket ring åpen ring anvendelige som modulatorer av chemokin-reseptor-aktivitet. Forbindelsene er anvendelige ved behandling og forebygging av AIDS-viruset. Mellomprodukter anvendelige ved fremstilling av sluttproduktene og farmasøytiske preparater inneholdende sluttproduktene er også omfattet.The present invention is a new series of functionalized heterocyclic groups as chemokine receptor modulators of formula 1 closed ring open ring useful as modulators of chemokine receptor activity. The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products and pharmaceutical compositions containing the final products are also included.

NO20013456A 1999-01-13 2001-07-12 Functionalized heterocycles as chemokine receptor modulators NO20013456L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11565499P 1999-01-13 1999-01-13
PCT/US1999/030434 WO2000042045A2 (en) 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators

Publications (2)

Publication Number Publication Date
NO20013456D0 NO20013456D0 (en) 2001-07-12
NO20013456L true NO20013456L (en) 2001-09-12

Family

ID=22362668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013456A NO20013456L (en) 1999-01-13 2001-07-12 Functionalized heterocycles as chemokine receptor modulators

Country Status (20)

Country Link
EP (1) EP1144415A2 (en)
JP (1) JP2002534526A (en)
KR (1) KR20010086166A (en)
CN (1) CN1344270A (en)
AP (1) AP2001002228A0 (en)
AU (1) AU1940900A (en)
BR (1) BR9916905A (en)
CA (1) CA2372197A1 (en)
CZ (1) CZ20012502A3 (en)
EA (1) EA200100774A1 (en)
HK (1) HK1044539A1 (en)
HU (1) HUP0202932A3 (en)
IL (1) IL144289A0 (en)
MX (1) MXPA01007033A (en)
NO (1) NO20013456L (en)
OA (1) OA11820A (en)
PL (1) PL349348A1 (en)
SK (1) SK9972001A3 (en)
WO (1) WO2000042045A2 (en)
ZA (1) ZA200106592B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951848B2 (en) 2001-03-12 2005-10-04 Millennium Pharmaceuticals, Inc., Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
HU230322B1 (en) 2001-03-29 2016-01-28 Eli Lilly And Co. N-(2-arylethyl)-benzylamines as antagonists of the 5-ht6 receptor and pharmaceutical compositions containing them
WO2003035650A1 (en) * 2001-09-25 2003-05-01 Takeda Chemical Industries, Ltd. Entry inhibitor
TWI344955B (en) 2003-03-14 2011-07-11 Ono Pharmaceutical Co Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
US7498323B2 (en) 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
PE20060598A1 (en) 2004-09-13 2006-08-21 Ono Pharmaceutical Co HETEROCYCLE DERIVATIVE CONTAINING NITROGEN AS ANTAGONIST OF CCR5 CHEMOKINE
EP1889622A4 (en) 2005-05-31 2009-12-23 Ono Pharmaceutical Co Spiropiperidine compound and medicinal use thereof
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007049771A1 (en) 2005-10-28 2007-05-03 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
ES2407115T3 (en) 2005-11-18 2013-06-11 Ono Pharmaceutical Co., Ltd. Compound containing a basic group and its use
CN101460458A (en) 2006-02-15 2009-06-17 阿勒根公司 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
EP1984334B1 (en) * 2006-02-15 2014-04-09 Allergan, Inc. Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
EP1995246A4 (en) 2006-03-10 2010-11-17 Ono Pharmaceutical Co Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
JP5257068B2 (en) 2006-05-16 2013-08-07 小野薬品工業株式会社 Compound containing acidic group which may be protected and use thereof
WO2007136300A2 (en) * 2006-05-23 2007-11-29 Alla Chem, Llc Substituted indoles and a method for the production and use thereof
US20090325992A1 (en) 2006-07-31 2009-12-31 Ono Pharmaceutical Co., Ltd. Compound having cyclic group bound thereto through spiro binding and use thereof
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
JP2010515750A (en) * 2007-01-11 2010-05-13 アラーガン インコーポレイテッド 6-Substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
CA2799154A1 (en) 2010-05-12 2011-11-17 Abbvie Inc. Indazole inhibitors of kinase
US20140271680A1 (en) 2011-08-12 2014-09-18 Universite Paris-Est Creteil Val De Marne Methods and pharmaceutical compositions for treatment of pulmonary hypertension
JO3459B1 (en) 2012-09-09 2020-07-05 H Lundbeck As Pharmaceutical compositions for treating alzheimer's disease
CN104193669B (en) * 2014-08-01 2016-12-07 大连理工大学 One class Abiduoer analog or its salt, its preparation method and application
WO2016112088A1 (en) * 2015-01-06 2016-07-14 Spero Therapeutics, Inc. Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
CN110256324A (en) * 2019-06-13 2019-09-20 苏州莱安医药化学技术有限公司 A kind of preparation method of 2- methyl -5-OHi

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549641A (en) * 1966-06-28 1970-12-22 Warner Lambert Pharmaceutical Pyrano pyridines and process for their production
US3518258A (en) * 1967-05-09 1970-06-30 Warner Lambert Pharmaceutical Pyrano(3,2-i)quinolizine and process for the production
US3565903A (en) * 1967-11-24 1971-02-23 Warner Lambert Pharmaceutical Pyrano(2,3-b)quinolines and process for their production
US5635510A (en) * 1993-05-06 1997-06-03 Merrell Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
AU745687B2 (en) * 1997-02-26 2002-03-28 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCR1 receptor
JP2002501898A (en) * 1998-02-02 2002-01-22 メルク エンド カムパニー インコーポレーテッド Cyclic amine modulators of chemokine receptor activity

Also Published As

Publication number Publication date
KR20010086166A (en) 2001-09-08
CA2372197A1 (en) 2000-07-20
CZ20012502A3 (en) 2002-03-13
OA11820A (en) 2005-08-17
MXPA01007033A (en) 2003-07-21
HK1044539A1 (en) 2002-10-25
NO20013456D0 (en) 2001-07-12
HUP0202932A2 (en) 2002-12-28
JP2002534526A (en) 2002-10-15
EA200100774A1 (en) 2002-02-28
IL144289A0 (en) 2002-05-23
PL349348A1 (en) 2002-07-15
WO2000042045A2 (en) 2000-07-20
AP2001002228A0 (en) 2001-09-30
AU1940900A (en) 2000-08-01
ZA200106592B (en) 2002-08-12
SK9972001A3 (en) 2002-03-05
EP1144415A2 (en) 2001-10-17
HUP0202932A3 (en) 2003-07-28
BR9916905A (en) 2002-01-29
WO2000042045A3 (en) 2000-11-09
CN1344270A (en) 2002-04-10

Similar Documents

Publication Publication Date Title
NO20013456L (en) Functionalized heterocycles as chemokine receptor modulators
MY125749A (en) Aralkyl and aralkylidene heterocyclic lactams and imides
TR200101961T2 (en) 1,2-ring quinoline derivatives
NO20050073L (en) Ring-substituted diphenyllazetidinones, their preparation, their use, and drugs containing the compounds
ATE353327T1 (en) THIOPHENE COMPOUNDS AS MEDICINAL PRODUCTS
AU6461600A (en) Substituted piperidine compounds useful as modulators of chemokine receptor activity
TR199800655T2 (en) New heterocyclic derivatives and their pharmaceutical uses.
HUP0000965A2 (en) Pyrrolidine derivatives having phospolipase a2 inhibitory activity and pharmaceutical compositions containing the same
HUP0401886A2 (en) Piperidine derivatives useful as modulators of chemokine receptor activity, process for their preparation and pharmaceutical compositions containing them
ATE208777T1 (en) (A)-ANNELATED PYRROLE DERIVATIVES AND THEIR APPLICATION IN PHARMACY
MY123193A (en) Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same
CA2285037A1 (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
FR2800074B1 (en) NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE223917T1 (en) (A)-ANNELATED PYRROLE DERIVATIVES AND THEIR APPLICATION IN PHARMACY
NO971625L (en) Novel peptides with immunomodulatory effects
SE9902765D0 (en) Novel compounds
HUP0400316A2 (en) 5-subtituted-2-arylpyridines as crf1 modulators and pharmaceutical compositions containing them
ES2154830T3 (en) DERIVATIVES OF 2-AMINOLACTAMA N- (4-SUBSTITUTED BENCILO).
DE60035988D1 (en) IRON-CHELATORS AND MEDICAMENTS CONTAINING IRON-CHELATORS FOR THE TREATMENT OF NEURODE-GENERATIVE DISEASES
HUP0301594A2 (en) Pharmaceutical compositions containing e-meta-nicotine diacyl tartaric acid salt and their use for treating of cns-disorders
ATE309803T1 (en) SPHINGOMYELINASE INHIBITORS AS ACTIVE INGREDIENTS WITH ANTIAPOPTOTIC AND ANTISEPTIC EFFECTS
ATE209633T1 (en) PYRIDINE DERIVATIVES, AS MEDICINAL PRODUCTS FOR THE TREATMENT OF ULCERS AND AS ANTIBACTERIAL AGENTS
HUP0400889A2 (en) Processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and pharmaceutical compositions containing the compound
TR200003797T2 (en) New preparations derived from alpha-D-xylose, their preparation methods and uses for treatment.
TNSN00095A1 (en) NOVEL SUBSTITUTED CYCLIC BENZOLACTAMES AND THIOAMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application